Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/28/2000 | WO2000056909A1 Anti-neoplastic viral agents comprising toxin gene under control of tumour cell-derived transcription factors |
09/28/2000 | WO2000056908A2 Maize chitinases and their use in enhancing disease resistance in crop plants |
09/28/2000 | WO2000056907A1 Control of sporocyte or meiocyte formation in plants |
09/28/2000 | WO2000056906A1 Chimeric promoters based on the plastocyanin pete promoter from pea |
09/28/2000 | WO2000056905A2 Method for enhancing and/or improving plant growth and/or yield or modifying plant architecture |
09/28/2000 | WO2000056904A1 A process for the selection of transgenic cells in the meristematic region of cotton, coffee, cocoa, banana or grape |
09/28/2000 | WO2000056903A2 IMPROVED METHODS FOR PRODUCING PROTEINS IN TRANSFORMED $i(PICHIA) |
09/28/2000 | WO2000056902A1 Polynucleotides for mutagenesis in fungus comprising a functional gene in magnaporthe and an impala tranposon |
09/28/2000 | WO2000056901A2 Linear and circular expression elements |
09/28/2000 | WO2000056900A2 Promoter sequences derived from fusarium venenatum and uses thereof |
09/28/2000 | WO2000056899A1 Dsp-2 dual-specificity map kinase phosphatase |
09/28/2000 | WO2000056898A1 Immortal microvascular endothelial cells and uses thereof |
09/28/2000 | WO2000056897A1 Inducible comtii promoter, chimera gene containing same and transformed plants |
09/28/2000 | WO2000056896A1 Hybrid synthetase, hybrid peptide and composition containing same |
09/28/2000 | WO2000056895A1 COTTON LEAF CURL VIRUS (CLCuV) PROMOTER AND ITS USE |
09/28/2000 | WO2000056894A1 Fungal beta-tubulin genes |
09/28/2000 | WO2000056893A1 Hyphal growth in fungi |
09/28/2000 | WO2000056892A1 METHOD FOR DETECTING ε-POLYLYSINE-PRODUCING BACTERIUM, PROCESS FOR PRODUCING ε-POLYLYSINE AND ε-POLYLYSINE-PRODUCING BACTERIUM |
09/28/2000 | WO2000056891A2 Human transmembrane proteins |
09/28/2000 | WO2000056890A1 Human fgf gene and gene expression products |
09/28/2000 | WO2000056889A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
09/28/2000 | WO2000056888A1 Rheumatoid arthritis gene and method for diagnosing rheumatoid arthritis |
09/28/2000 | WO2000056887A1 Katp channel |
09/28/2000 | WO2000056886A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |
09/28/2000 | WO2000056885A1 Protein for blocking platelet adhesion |
09/28/2000 | WO2000056883A1 49 human secreted proteins |
09/28/2000 | WO2000056882A1 48 human secreted proteins |
09/28/2000 | WO2000056881A1 48 human secreted proteins |
09/28/2000 | WO2000056880A1 50 human secreted proteins |
09/28/2000 | WO2000056878A1 Methods of obtaining full-length nucleic acid sequences using e. coli topoisomerase iii and its homologs |
09/28/2000 | WO2000056877A1 Method for amplifying nucleic acid sequence |
09/28/2000 | WO2000056876A1 Mutagenesis |
09/28/2000 | WO2000056875A1 Detection, cloning and sequencing of polypeptides which drive the subcellular localization of proteins |
09/28/2000 | WO2000056874A1 Retroviral vectors and methods for production and use thereof |
09/28/2000 | WO2000056872A2 High-throughput gene cloning and phenotypic screening |
09/28/2000 | WO2000056868A1 Trehalose synthase protein, gene, plasmids, microorganisms, and a process for producing trehalose |
09/28/2000 | WO2000056866A2 Akt-3 nucleic acids, polypeptides, and uses thereof |
09/28/2000 | WO2000056865A1 Histidine kinase |
09/28/2000 | WO2000056864A2 Methods for altering substrate specificity of phosphoinositide-dependent-protein kinase 1 (pdk1) |
09/28/2000 | WO2000056863A1 Banana and melon promoters for expression of transgenes in plants |
09/28/2000 | WO2000056862A1 Human tumor necrosis factor receptor tr9 |
09/28/2000 | WO2000056858A1 Process for producing l-lysine |
09/28/2000 | WO2000056857A1 Polynucleotide encoding a protein involved in chromosomal inheritance and method of use therefor |
09/28/2000 | WO2000056773A1 Antibodies specific for cyp1b1 |
09/28/2000 | WO2000056772A1 Human antibodies that bind human il-12 and methods for producing |
09/28/2000 | WO2000056771A1 Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders |
09/28/2000 | WO2000056770A1 ANTI-p53 ANTIBODIES |
09/28/2000 | WO2000056767A1 46 human secreted proteins |
09/28/2000 | WO2000056766A1 47 human secreted proteins |
09/28/2000 | WO2000056765A1 48 human secreted proteins |
09/28/2000 | WO2000056764A1 Dna molecules encoding human clax proteins and their soluble fusion proteins |
09/28/2000 | WO2000056755A1 49 human secreted proteins |
09/28/2000 | WO2000056754A1 48 human secreted proteins |
09/28/2000 | WO2000056753A1 49 human secreted proteins |
09/28/2000 | WO2000056752A2 Apoptosis related genes |
09/28/2000 | WO2000056751A1 50 human secreted proteins |
09/28/2000 | WO2000056748A1 Xylo-lna analogues |
09/28/2000 | WO2000056740A1 Boronic acid containing reagents and oligonucleotides |
09/28/2000 | WO2000056444A2 Spatially directed interaction on a solid surface |
09/28/2000 | WO2000056405A2 Human tumor necrosis factor receptor-like 2 |
09/28/2000 | WO2000056368A1 Gene therapeutics |
09/28/2000 | WO2000056360A2 Vaccine against antigens from bacteriae |
09/28/2000 | WO2000056359A2 Vaccine against streptococcus pneumoniae |
09/28/2000 | WO2000056358A2 Vaccine against streptococcus pneumoniae capsular polysaccharides |
09/28/2000 | WO2000056352A2 Reagents and methods useful for detecting diseases of the prostate |
09/28/2000 | WO2000056288A1 Nanoparticles, complexes with polynucleotides and their use |
09/28/2000 | WO2000056135A2 Human polypeptide receptors for lysophospholipids and sphingolipids and nucleic acids encoding the same |
09/28/2000 | WO2000043490A3 Rhamnosyl-transferase gene and uses thereof |
09/28/2000 | WO2000042972A3 Compositions and methods for intraductal gene therapy |
09/28/2000 | WO2000042221A3 Method for the affinity isolation of newly synthesized rna |
09/28/2000 | WO2000042195A3 Schizochytrium pks genes |
09/28/2000 | WO2000042194A3 Mutant hepatitis b surface antigen and testing |
09/28/2000 | WO2000041740A3 Particles for oral delivery of peptides and proteins |
09/28/2000 | WO2000041610A3 Mitochondrial dna damage as a predictor of coronary atherosclerotic heart disease |
09/28/2000 | WO2000041545A3 Regulators of the pct or smoothened pathway, compositions and uses related thereto |
09/28/2000 | WO2000041497A3 Use of apoptosis inducing agents in the treatment of (auto)immune diseases |
09/28/2000 | WO2000040710A3 Seed-preferred promoter |
09/28/2000 | WO2000040693A3 Expression of secreted human alpha-fetoprotein in transgenic animals |
09/28/2000 | WO2000031253A3 Mutation of the parkin gene, compositions, methods and uses |
09/28/2000 | WO2000029577A9 Novel members of the capsaicin/vanilloid receptor family of proteins and uses thereof |
09/28/2000 | WO2000026413A9 Determining signal transduction pathways |
09/28/2000 | WO2000026394A9 Variants of humanized anti-carcinoma monoclonal antibody cc49 |
09/28/2000 | WO2000024874A9 Recombinant extracellular chitinases and uses thereof |
09/28/2000 | WO2000023592A9 Minimal promoters and uses thereof |
09/28/2000 | WO2000023589A3 Proliferation and apoptosis related proteins |
09/28/2000 | WO2000022143A3 Protein kinase homologs |
09/28/2000 | WO2000022142A3 Cell signaling polypeptides and nucleic acids |
09/28/2000 | WO2000021559A3 Blocking factor b to treat complement-mediated immune disease |
09/28/2000 | WO2000020576A3 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein |
09/28/2000 | WO2000020447A3 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses |
09/28/2000 | WO2000020438A9 G protein-coupled receptor resembling the thrombin receptor |
09/28/2000 | WO2000018796A3 Secretory protein- zsig48 |
09/28/2000 | WO2000015793A3 Human gpcr proteins |
09/28/2000 | WO2000009722A3 Methods for controlling gibberellin levels |
09/28/2000 | WO2000009464A9 Identification of compound-protein interactions using libraries of protein-nucleic acid fusion molecules |
09/28/2000 | WO1999019475A3 Mammalian mesoderm induction early response (m-mier) gene family |
09/28/2000 | WO1999018234A3 Means for qualitative and quantitative analysis of microbial populations potentially present in a sample |
09/28/2000 | DE19939070A1 Use of nucleic acid encoding Leishmania kinases for identifying and preparing diagnostic, preventative and therapeutic agents |
09/28/2000 | DE19913506A1 New yeast-bacterium shuttle vector, useful e.g. for gene therapy, comprises chromosomal and regulatory elements plus marker genes, can accommodate large DNA fragments |
09/28/2000 | DE19911992A1 RNA Polymerase I Transkriptionsfaktor TIF-IA RNA polymerase I transcription factor TIF-IA |